AbbVie Highlights Robust Gastroenterology Portfolio with New

A total of 24 accepted abstracts, including six oral and digital oral presentations, reinforce AbbVie's commitment to research that helps advance standards of...

Related Keywords

Ohio , United States , Italy , Milan , Lombardia , Denmark , Copenhagen , Køavn , Silvio Danese , Ann Gastroenterol , Gastroenterol Hepatol , Abbvie Ltd , Peuropean Society Of Gastrointestinal Endoscopy , European Society Of Neurogastroenterology , Boehringer Ingelheim , Exchange Commission , University Vita , Allergan , Abbvie Inc , Colitis Organisation , Crohn Colitis Foundation Of America , European Crohn , Sofie Berg , European Society , Gastrointestinal Endoscopy , Plenary Hall , San Raffaele , University Vita Salute San Raffaele , Important Safety Information , Medication Guide , Consumer Brief Summary , Mississippi River , Full Prescribing Information , Allergic Reactions , Pregnancy Registry , Allergan Aesthetics , Private Securities Litigation Reform Act , Quarterly Reports , Inflammatory Bowel , Colitis Foundation , Rev Gastroenterol , North Chicago , Placebo Controlled Study , Endoscopic Remission , Subjects With Moderately , Severely Active Crohn , Disease Who Have Inadequately Responded , Are Intolerant , Participants With Giant Cell Arteritis , Study Comparing Upadacitinib , Participants With Psoriatic Arthritis Who Have , Inadequate Response , Compare Safety , Adult Participants With Moderate , Severe Atopic Dermatitis , Subjects With Takayasu Arteritis , Evaluate Efficacy , Adult Participants With Axial Spondyloarthritis , Placebo Controlled Induction Study , Participants With Moderately , Severely Active Ulcerative , Abbvie ,